Nutrition 21’s Board of Directors brings an additional level of expertise and strategic oversight to the organization.


Phillip M. Satow is Chairman of the Board of Directors at Nutrition 21. Phillip comes to Nutrition 21 with more than 30 years of experience in the pharmaceutical industry. He was Co-founder, Chairman and CEO of JDS Pharmaceuticals, a specialty pharmaceutical company focused on the psychiatry and women’s health markets. Phillip and his son, Michael, grew JDS to more than $30 million in sales in three years, before selling the company to Noven Pharmaceuticals in 2007 for $125 million.

Prior to founding JDS, Phillip served as Executive Vice President of Forest Laboratories, where he oversaw all marketing and sales functions. He also held the position of President of Forest Pharmaceuticals and was a former member of the Forest Board of Directors. At Forest, Phillip built the company’s sales and marketing infrastructure and retired after launching Forest’s first $1 billion product – the anti-depressant Celexa. Prior to joining Forest, he served as Vice President and General Manager of the Wallace Laboratories Division of Carter–Wallace. In addition, he has held a variety of executive positions at Pfizer, including Director of Marketing of Pfizer Laboratories and Vice President of Pfizer Europe. Phillip has also served on the boards of directors of Crucell, Eyetech and Noven, as well as various others.

Phillip received a BA from Columbia College and an MA from Georgetown University.


Michael S. Satow is President and CEO of Nutrition 21. An entrepreneur, Michael joins Nutrition 21 from JDS Pharmaceuticals, a specialty pharmaceutical company focused on the psychiatry and women’s health markets. Michael served as President and Chief Operating Officer of JDS and successfully sold to Noven Pharmaceuticals for $125 million.

Michael began his career as an attorney in private practice and as an enforcement lawyer at the SEC. In 1997, after five years of practicing law, Michael founded and served as CEO of MarketXT, the first retail afterhours stock market, with backing from Morgan Stanley and Salomon Smith Barney. For his work with MarketXT, Michael was named one of the Top 10 American Innovators by US News & World Report. He sold this venture in 2000 for $100 million. From 2000 to 2002, he served as CEO of Mirror Worlds Technologies, a knowledge management software company and the makers of Scopeware.

He currently serves on the board of directors of Houseparty Inc. and Skymarker LLC. In addition, Michael serves on the boards of The Jed Foundation, a leading charity focused on protecting the mental health of students across the country, and My Sister’s Place, Westchester’s primary domestic violence agency.

Michael received a BA from Columbia College and a JD from the Georgetown University Law Center.


Robert F. Johnston founded Johnston Associates in 1968, a venture capital firm with emphasis in the pharmaceutical and biotechnology industries. In the mid-70s, he founded a number of biotechnology and healthcare companies, including Cytogen, Ecogen, Sepracor, i-STAT, Envirogen and Praelux (formerly SEQ). Robert was also instrumental in the early formations of Sonomed, Biocyte, Immunicon and VelaPharm. Prior to founding Johnston Associates, he was an investment banker for F.S. Smithers & Co. and for Smith Barney & Co. in New York.

Robert received a BA from Princeton University and an MBA from New York University.


Richard Pechter joined Donaldson, Lufkin & Jenrette in 1969 and retired in 2000 as a Director and Chairman of the firm’s Financial Services Group and Chairman of DLJDirect, the firm’s internet brokerage company. He has served as President of the Investment Association of New York, Vice Chairman of the Securities Industry Association, a trustee of the Securities Industry Institute and a Director of National Securities Clearing Corporation, the Depository Trust Company, and Interstate Securities. He is currently a Director of the Financial Industry Regulatory Authority (FINRA) and the New York Stock Exchange Regulatory Authority. In addition, he is a current member of the Bond Club, the Yale Club, the Friars, the National Arts Club and Kappa Beta Phi.

After his retirement from DLJ, Richard joined Teach for America and spent five years teaching math at a community college and a Jersey City public high school. He chaired the NJ Board of Teach for America for several years and currently serves on Teach for America’s National Board. Richard won a Tony award in 1997 as a producer of the award winning musical Titanic.

Richard received a BA from Yale University and an MBA from Harvard.


Frederic M. Poses has served as CEO and Partner of Ascend Performance Materials, a private manufacturer of nylon related chemicals, resins and fibers for commercial and industrial products, since June 2009.

From 1999 to 2008, he was Chairman and CEO of Trane (previously American Standard Companies), a global manufacturer and provider of air conditioning systems and services, vehicle control systems and bathroom and kitchen fixtures and fittings. From 1998 to 1999, he served as President and COO at AlliedSignal. Before joining AlliedSignal in 1969, Frederic spent two years in Peru with the Peace Corps.

In addition, Frederic has served as the non-executive Chairman of the Tyco Electronics Board of Directors since its inception in June 2007. He is a Director of Raytheon Company, Chairman of the Board of the National Center for Learning Disabilities and a trustee of the Eagle Hill School, the 92nd Street Y and the Central Synagogue.

Frederic received a BA from New York University.